enhance discoveries | accelerate potential · how: a cnn trained to learn the focus of the gaze,...

2
Enhance discoveries | Accelerate potential We are a team of data science experts partnering with early stage biotech and medical device companies as consultants or as a risk partner to integrate analytics and machine learning capabilities to improve care, enhance discoveries, and enable data-driven decisions. Our multidisciplinary scientists are trained in computational biology, genomics, bioinformatics, pharmacology, neuroscience, biophysics, and data science. Born out of the venture capital world, we were created by investors to accelerate early stage, high growth companies, the stars of innovation in the biomedical world. Our proprietary omics-AI platform enables us to rapidly use data science techniques at scale to visualize and extract insights from phenotypic, genomic and proteomic data, in the context of global biomedical knowledge. Our data engineering platform includes pre-built, cloudscale data pipelines to find signal in structured and unstructured data: biological data, time series data, imaging, video and audio. Our platform rapidly prepares data for use and experimentation in advanced AI/ML to train predictive models, including deep learning algorithms and natural language processing. We use machine learning to develop biomarkers and digital diagnostic tools based on genomic data, medical device data, medical images, video analytics, and EHR clinical data OUR IMPACT WHO WE HELP WHAT WE DO Life sciences + AI LIFE SCIENCES & HEALTHCARE Insights + Applications We use data science techniques to analyze and extract insights from complex and large scale scientific and biological data including genomics, proteomics, metabolomics Bioinformatics Digital diagnostics and biomarkers We build AI driven applications to enhance discovery, diagnosis and treatment Accelerate the build of your AI application 3737 Buffalo Speedway, Suite 620 Houston, TX, 77098 E: [email protected] MOVE FASTER, TODAY We can help you use AI to power your approach, hit your milestones and raise the next round of capital. Contact us to get started.

Upload: others

Post on 12-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Enhance discoveries | Accelerate potential · How: A CNN trained to learn the focus of the gaze, and assess a new individual in areas of dementia, concussion, and intoxication Our

Enhance discoveries | Accelerate potential

We are a team of data science experts partnering with early stage

biotech and medical device companies as consultants or as a risk

partner to integrate analytics and machine learning capabilities

to improve care, enhance discoveries, and enable data-driven

decisions. Our multidisciplinary scientists are trained in

computational biology, genomics, bioinformatics, pharmacology,

neuroscience, biophysics, and data science.

Born out of the venture capital world, we were created by

investors to accelerate early stage, high growth companies, the

stars of innovation in the biomedical world.

Our proprietary omics-AI platform enables us to rapidly use

data science techniques at scale to visualize and extract insights

from phenotypic, genomic and proteomic data, in the context of

global biomedical knowledge.  Our data engineering platform includes pre-built, cloudscale datapipelines to find signal in structured and unstructured data:biological data, time series data, imaging, video and audio. Ourplatform rapidly prepares data for use and experimentation inadvanced AI/ML to train predictive models, including deeplearning algorithms and natural language processing.

We use machine learning to develop biomarkers

and digital diagnostic tools based on genomic

data, medical device data, medical images, video

analytics, and EHR clinical data

OUR IMPACT

WHO WE HELP

WHAT WE DO

Life sciences + AI

LIFE SCIENCES & HEALTHCARE

Insights + Applications

We use data science techniques to analyze

and extract insights from complex and large

scale scientific and biological data including

genomics, proteomics, metabolomics

Bioinformatics

Digital diagnostics and biomarkers

We build AI driven applications to enhance

discovery, diagnosis and treatment

Accelerate the build of your AI application

3737 Buffalo Speedway,

Suite 620 Houston, TX, 77098 E: [email protected]

MOVE FASTER, TODAY

We can help you use AI to power your approach, hit your milestones

and raise the next round of capital. Contact us to get started.

Page 2: Enhance discoveries | Accelerate potential · How: A CNN trained to learn the focus of the gaze, and assess a new individual in areas of dementia, concussion, and intoxication Our

Who: A pulmonary therapeutics company What: Determine the MOA of a novel drug candidate based on afunctional proteomics assay of diseased and treated tissues How: Use data science to quantify differences in proteinexpression to identify involved genes, proteins, and pathways

Who: An agricultural biotech company What: Identify key genes to optimize plant traits How: Used machine learning to identify the association ofgenomic variants to plant traits (GWAS). Developed NLP modelsto gain context of global biomedical knowledge.

Who: A neurobehavior therapeutics company What: Improve the diagnosis of patients with depression and anxiety How: Time series audio and video data feature engineered to traina model for predicting clinical outcomes

Who: A nutriceutical therapeutics company What: Determine MOA of a compound with proven health benefitsto support AI drug discovery techniques to identify similarcompounds How: Data science methods to identify proteomic activity incontext of biomedical knowledge of genes, pathways, diseases

Who: A digital cognitive assessment company What: Develop a tablet-based real time application to assess cognitiveperformance based on a person’s ability to track a visual stimulus How: A CNN trained to learn the focus of the gaze, and assess a newindividual in areas of dementia, concussion, and intoxication

Our work in health

Identify a drug’s mechanism of action by

integrative analysis of proteomics

LIFE SCIENCES & HEALTHCARE

3737 Buffalo Speedway,

Suite 620 Houston, TX, 77098 E: [email protected]

MOVE FASTER, TODAY

We can help you use AI to power your approach, hit your milestones

and raise the next round of capital. Contact us to get started.

Build an AI platform to find targets of genetic

engineering to improve crop yield

Who: A cancer therapeutics company What: Evaluate novel cancer therapeutic targets How: Used NLP to extract gene to disease relationships from 2 TB of scientific literature, clinical trials and patents to providecontext for newly discovered targets

A better way to prioritize drug targets

Create a digital diagnostics platform for

behavioral health

Automate discovery of advanced nutritional products

Guide medical diagnosis with eye biometric tracking

Enhance discoveries | Accelerate potential